Ray Solano shares how novel delivery systems improve absorption of methylene blue, LDN, and hormones to support Lyme and chronic illness care.

Ray Solano, head of PD Labs, introduces an innovative drug delivery system that makes powerful compounds more effective and better tolerated. He explains how nanoscale, phospholipid-encapsulated formulations dramatically improve absorption of methylene blue, testosterone, and low-dose naltrexone—allowing patients to benefit from lower doses with fewer side effects. This approach offers exciting promise for chronic illness, Lyme disease, and hormone therapies.

Ray Solano is the President of PD Labs, a compounding pharmacy specializing in advanced delivery systems for complex medications and nutraceuticals. With decades of experience, he has pioneered novel formulations that increase absorption and reduce side effects of therapies such as methylene blue, low-dose naltrexone, and hormones. Through collaborations with physicians and researchers, Ray is helping to transform chronic illness treatment with safe, effective, and patient-centered innovations.